Navigation Links
ReSearch Pharmaceutical Services, Inc. Unaudited Quarterly Report for the Period Ended September 30, 2009
Date:11/13/2009

Net income $994,033 $748,239 $1,982,762 $3,224,372 --------- -------- ---------- ---------- Net income per common share: Basic $0.03 $0.02 $0.05 $0.10 Diluted $0.03 $0.02 $0.05 $0.09 Weighted average number of common shares outstanding: Basic 37,231,635 32,547,406 36,910,087 32,507,708 Diluted 38,141,116 34,049,551 37,955,539 34,069,060

         ReSearch Pharmaceutical Services, Inc. and Subsidiaries
             Condensed Consolidated Statements of Cash Flows

                                                       Nine Months Ending
                                                         September 30,
                                                      2009           2008
                                                      ----           ----
                                                          (unaudited)
    Net income                                  $1,982,762     $3,224,372
    Adjustments to reconcile net income to
      net cash (used in) provided by operating
     activities:
     Depreciation and amortization               2,554,806      1,233,451
     Stock-based compensation                      453,630        413,771
     Deferred tax benefit                         (317,115)             -
     Changes in operating assets and
      liabilities:
     Accounts receivable                        (7,298,979)    (1,897,447)
     Prepaid expenses and other assets             383,865       (968,379)
     Accounts payable                             (582,190)        17,973
     Accrued expenses and other liabilities      1,849,424       (518,930)
     Customer deposits                          (2,559,107)      (307,155)
     Deferred revenue                            1,761,991     (1,640,451)
               
'/>"/>
SOURCE ReSearch Pharmaceutical Services, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Dr. Steven M. Paul to Retire from Lilly as Executive Vice President, Science and Technology, President, Lilly Research Laboratories; Dr. Jan M. Lundberg, Executive Vice President, Head of Global Discovery Research, AstraZeneca, Named his Successor
2. New Research Shows Over-use of Asthma Rescue Inhalers Substantially Reduced Through Pharmacist-initiated Physician Intervention
3. New Research Shows Promise in Using Traditional Research Methods to Assess Efficacy of Complementary Therapies
4. Executives Reveal Secrets to Capitalize on New Developments in Pharmaceutical Marketing Research
5. Reportlinker Adds The Global Drug Delivery Market: Research Trends and Market Outlook
6. Sigma-Aldrich Enters Distribution Agreement With Stemgent, Inc. to Offer Lentivirus-Based Gene Delivery Products for Regenerative Medicine and Stem Cell Research
7. Celling Technologies Signs Exclusive Agreement to Research and Develop Adipose Tissue Stem Cell Technology in Regenerative Medicine Institutes
8. Monsanto to Purchase Chesterfield Village Research Center From Pfizer
9. Bend Research and Vertex Pharmaceuticals Enter New Scientific Collaboration
10. Cantel Medical Corp. to Present at the Sidoti Emerging Growth Research Institutional Investor Forum
11. Codexis Names Fernando Valle Research Fellow
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... Sept. 30, 2014 This study provides ... imaging informatics solutions including nuclear imaging informatics, PET ... The study assesses the size of the market ... 2013, and projects future growth based on the ... dynamics taking place in the broader markets for ...
(Date:9/30/2014)... 30, 2014  Decision Resources Group finds that the ... , China , India , ... strong rate through 2023. Dental implant procedure volumes will grow as ... rises. Other key findings from Decision Resources Group,s coverage ... , Dental implant penetration: Penetration of dental implants ...
(Date:9/30/2014)... 2014 A study using a relatively new ... look at the composition of carotid artery disease and ... treat the disease, a leading cause of stroke. ... between September 2010 and May 2012, was featured in ... the American College of Cardiology (JACC) Cardiovascular Interventions. ...
Breaking Medicine Technology:Analysis of the US Molecular Imaging Informatics Market 2Analysis of the US Molecular Imaging Informatics Market 3Asia Pacific Dental Implant Market Will Grow at a Strong Rate Through 2023 2Asia Pacific Dental Implant Market Will Grow at a Strong Rate Through 2023 3New Imaging Tool May Allow Tailoring of Stroke Prevention to Each Patient 2
... Lilly and Company (NYSE: LLY ) today ... Radiopharmaceuticals, Inc., a privately held company developing novel molecular ... chronic human diseases. The transaction, first announced on November ... and clearance under the Hart-Scott-Rodino Antitrust Improvements Act. All ...
... year, the Food and Drug Administration (FDA) approves many ... and help consumers save money. To read ... to http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm236544.htm . Sign up for ... https://service.govdelivery.com/service/subscribe.html?code=USFDA_9 . View the ...
Cached Medicine Technology:Lilly Announces Completion of Avid Acquisition and FDA Priority Review for florbetapir 2
(Date:9/30/2014)... TUESDAY, Sept. 30, 2014 (HealthDay News) -- Children conceived either ... the birth of a sibling could be at increased risk ... study,s lead author and an outside expert agree that the ... in autism. "Most importantly, it is important that parents ... even when pregnancies are close together or far apart," said ...
(Date:9/30/2014)... "brain tsunamis" in injured patients without opening the ... thanks to pioneering research at the University of ... led by Jed Hartings, PhD, research associate professor ... College of Medicine, has shown that spreading depolarizationselectrical ... tsunami wavescan be measured by the placement of ...
(Date:9/30/2014)... Next to lung cancer, breast cancer is the leading ... American Cancer Society. That,s why so many medical professionals ... are imperfect at best: only a minority of suspicious ... results in lots of needless worry for women and ... of additional tests, including ultrasounds and biopsies. , ...
(Date:9/30/2014)... slow the spiraling costs of drugs paid for by ... no meaningful impact on cancer chemotherapy drug costs, say ... Clinical Oncology published online today. , "We looked ... lung cancers, and did not find a substantial change ... of the recent Medicare law in 2005," says the ...
(Date:9/30/2014)... Integrated Medicine Alliance , Monmouth County’s leader ... specialty practice through a unique partnership with an established ... within the company’s Shrewsbury location and will be staffed ... American Heart Center, P.C., a highly regarded practice located ... Medicine Alliance patients top notch cardiovascular care without leaving ...
Breaking Medicine News(10 mins):Health News:Spacing Between Sibling Births Tied to Autism Risk in Study 2Health News:Researchers show EEG's potential to reveal depolarizations following TBI 2Health News:Researchers show EEG's potential to reveal depolarizations following TBI 3Health News:'Virtual breast' could improve cancer detection 2Health News:Landmark Medicare law had little impact on reducing chemotherapy cost 2Health News:Integrated Medicine Alliance Announces New Cardiology Practice 2
... FAIRFAX, Va., July 27 A new proposal from the Centers ... therapy treatments would cause many cancer centers to close, stop accepting ... patients, according to a survey conducted by ASTRO, the American Society ... technology has allowed radiation oncologists to improve cancer cure rates while ...
... , St. Jude scientists identify new ... the need for more detailed look at the complete AML genome ... The most comprehensive analysis yet of the genome of childhood acute ... blueprint, suggesting the cancer arises from just a handful of missteps, ...
... serious complications drop with intensive therapy, study shows , ... blood sugar levels and taking medications that lower blood ... significantly reduce their risk of developing the most serious ... In a study appearing in the July 27 issue ...
... , , SWIFTWATER, ... Group (EURONEXT: SAN and NYSE: SNY ), announced today ... of Fluzone((R)), Influenza Virus Vaccine. Fluzone vaccine is indicated for active ... disease caused by influenza virus subtypes A and type B contained ...
... , DENVER, July 27 ... come together to offer Chamber members a health plan solution that ... traditional and alternative medical care. Whether members choose to treat a ... regimens, the Chamber Plan,s BlueFreedom accommodates their healing preferences. Most plan ...
... , MONDAY, July 27 (HealthDay News) -- Ozone levels ... on lung function in healthy people, say U.S. researchers. , ... of up to 75 parts per billion over an eight-hour ... to mean ozone concentrations as low as 70 parts per ...
Cached Medicine News:Health News:Medicare Cuts Will Force Many Cancer Centers To Close, Stop Seeing Medicare Patients, Lay Off Staff, According To ASTRO Survey 2Health News:Medicare Cuts Will Force Many Cancer Centers To Close, Stop Seeing Medicare Patients, Lay Off Staff, According To ASTRO Survey 3Health News:Medicare Cuts Will Force Many Cancer Centers To Close, Stop Seeing Medicare Patients, Lay Off Staff, According To ASTRO Survey 4Health News:Comprehensive Look at Rare Leukemia Finds Relatively Few Genetic Changes Launch Disease 2Health News:Comprehensive Look at Rare Leukemia Finds Relatively Few Genetic Changes Launch Disease 3Health News:Comprehensive Look at Rare Leukemia Finds Relatively Few Genetic Changes Launch Disease 4Health News:Tight Management of Type 1 Diabetes Worth the Effort 2Health News:Tight Management of Type 1 Diabetes Worth the Effort 3Health News:Sanofi Pasteur Begins Shipments of Fluzone(R), Influenza Virus Vaccine for 2009-2010 Seasonal Influenza 2Health News:Sanofi Pasteur Begins Shipments of Fluzone(R), Influenza Virus Vaccine for 2009-2010 Seasonal Influenza 3Health News:Sanofi Pasteur Begins Shipments of Fluzone(R), Influenza Virus Vaccine for 2009-2010 Seasonal Influenza 4Health News:Sanofi Pasteur Begins Shipments of Fluzone(R), Influenza Virus Vaccine for 2009-2010 Seasonal Influenza 5Health News:Sanofi Pasteur Begins Shipments of Fluzone(R), Influenza Virus Vaccine for 2009-2010 Seasonal Influenza 6Health News:Anthem Blue Cross and Blue Shield Introduces a Health Insurance Solution With a Special 'Boulder Flair' to Chamber Members 2Health News:'Safe' Ozone Levels May Not Be for Some 2
... first 192 channel simultaneous sampling EEG with ... routine EEG exam rooms as well as ... Optional analysis software for automatic spike ... sleep analysis. Quality Data Acquisition ,The ...
Optoelectronic stimulator, "ganzfeld" stimulations for flash VEP, flash ERG and sensory EOG. Pattern stimulations for ERG and VEP, multifocal stimulations for ERG and VEP, complies with international...
... The VISULAS 690s is the ... the instrument of choice for ... clinical trials, Carl Zeiss has ... in laser manufacturing to create ...
The SL 115 Classic Slit Lamp offers you high optical performance and convenient operation. It is not only the ideal instrument for all routine examinations and contact lens fitting, but is also excel...
Medicine Products: